Klin Farmakol Farm. 2010;24(3):145-151
The knowledge on the importance of drugs´ teratogenity plays a significant role in the process of rational pharmacotherapy. Women
represent almost half of adult patients and a part of them is in fertile period when the potential teratogenity risk should be considered.
The drugs could be administered for a long time or for a short term treatment of acute conditions. The teratogenic effect of a drug
depends on: the period of pregnancy in time when the drug is applied, the duration of drug administration, genotype of mother and
foetus, dosage of active substance which is effecting on foetus. It is estimated that drugs contribute to development up to 5 % of all foetal
anatomic abnormalities. Teratogenic agents may cause barely observable abnormalities of biochemical and physiologic processes as
well as changes in behaviour, however the dosages of teratogens are much more less than those causing anatomic abnormalities. Many
of these latent abnormalities are not observed after birth and they are revealed many years later. The most important factor which plays
an important role in doctor’s decision making process before administration of a drug is the consideration of benefit of treatment of
disease of mother, evaluation whether the mother’s disease may cause teratogenic effect and whether mother’s recovery may lead to
improvement of health status of foetus. The authors list the examples of teratogenic effects of concrete drugs during pregnancy.
Published: October 15, 2010 Show citation